Fierce Biotech's 2022 Fierce 15
By Ben Adams | Sep 12, 2022
Innovation cannot happen in a silo. And this year we have mirrored this need, focusing more than ever before on diversity in management and geography across the biotech world, highlighting a broader range of teams, leaders and science in our Fierce 15 winning companies.
And what a crop we have picked out as the honorees for 2022. Their scientific roots run deep. We have biotechs seeking cures for incurable genetic diseases and companies seeking to tap the latest digital tech in artificial intelligence and machine learning to discover better drugs faster. There are those that want to drug the undruggable, while others tapping RNA to treat cancer or leveraging older promising technology but using cutting-edge techniques to shield patients from a drug’s toxicity.